Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025
- DOI
- 10.2807/1560-7917.es.2025.30.45.2500816
- Published
- 2025-11-13
- Container
- Eurosurveillance
- Publisher
- European Centre for Disease Control and Prevention (ECDC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2807/1560-7917.es.2025.30.45.2500816,
title = {Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged \< 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025},
author = {Camelia Savulescu and Iris Ganser and Nathalie Nicolay and Adrien Lajot and Sandra Campos and Iván Martínez-Baz and Ana Paula Rodrigues and Mathil Vandromme and Marta Cara-Rodríguez and Aitziber Echeverría and Vânia Gaio and Marie-Pierre Parsy and Ana Roldan Garrido and Jesús Castilla and Raquel Guiomar and Sabrina Bacci and Angela MC Rose and Unknown},
year = {2025},
journal = {Eurosurveillance},
doi = {10.2807/1560-7917.es.2025.30.45.2500816},
url = {https://doi.org/10.2807/1560-7917.es.2025.30.45.2500816}
}RIS
TY - JOUR TI - Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025 AU - Camelia Savulescu AU - Iris Ganser AU - Nathalie Nicolay AU - Adrien Lajot AU - Sandra Campos AU - Iván Martínez-Baz AU - Ana Paula Rodrigues AU - Mathil Vandromme AU - Marta Cara-Rodríguez AU - Aitziber Echeverría AU - Vânia Gaio AU - Marie-Pierre Parsy AU - Ana Roldan Garrido AU - Jesús Castilla AU - Raquel Guiomar AU - Sabrina Bacci AU - Angela MC Rose AU - Unknown PY - 2025 JO - Eurosurveillance DO - 10.2807/1560-7917.es.2025.30.45.2500816 UR - https://doi.org/10.2807/1560-7917.es.2025.30.45.2500816 ER -
APA
Savulescu, C., Ganser, I., Nicolay, N., Lajot, A., Campos, S., Martínez-Baz, I., Rodrigues, A. P., Vandromme, M., Cara-Rodríguez, M., Echeverría, A., Gaio, V., Parsy, M., Garrido, A. R., Castilla, J., Guiomar, R., Bacci, S., Rose, A. M., & Unknown (2025). Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2025.30.45.2500816
Source records
- crossref · retrieved 2026-09-27T06:23:41.606Z